KidneyIntelX and KidneyIntelX.dkd Testing

KidneyIntelX and KidneyIntelX.dkd are covered once in a lifetime for patients older than 21 with type 2 diabetes and early-stage CKD (stages 1–3b) when the results will be used to inform therapeutic prognostic decision-making; the test must be ordered by the treating clinician, performed in a CLIA-certified high-complexity lab, and the medical necessity must be documented. The test is not covered for patients with eGFR ≥60 without albuminuria, patients with ESRD or on renal recovery treatments, pregnant or currently hospitalized patients, patients taking etanercept, or when used as a screening or standalone diagnostic; one line in the limitations re: eGFR is incomplete and requires manual review.

"KidneyIntelX or KidneyIntelX."

Sign up to see full coverage criteria, indications, and limitations.